Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001140361-24-041567
Filing Date
2024-09-20
Accepted
2024-09-20 16:17:05
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-1/A ny20033174x4_s1a.htm S-1/A 5850505
2 EXHIBIT 23.1 ny20033174x4_ex23-1.htm EX-23.1 1707
3 EXHIBIT 23.2 ny20033174x4_ex23-2.htm EX-23.2 2002
4 logo_cartesian.jpg GRAPHIC 51818
5 logo_cartesianx1.jpg GRAPHIC 58064
6 ny20033174x4_diagram01.jpg GRAPHIC 238752
7 ny20033174x4_diagram02.jpg GRAPHIC 123565
8 ny20033174x4_diagram03.jpg GRAPHIC 155500
9 ny20033174x4_linecharts01.jpg GRAPHIC 300512
10 ny20033174x4_linecharts02.jpg GRAPHIC 219493
11 ny20033174x4_safety.jpg GRAPHIC 519606
  Complete submission text file 0001140361-24-041567.txt   8150081
Mailing Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878
Business Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-281204 | Film No.: 241313603
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)